JOHN G. KOELTL, District Judge.
Daniel Cameron, a medical doctor, brings this action against numerous defendants accusing them of conspiracy to violate the Sherman Act, 15 U.S.C. §§ 1, 2. He also alleges that the defendants violated his constitutional rights and provisions of the New York Public Health Law. Dr. Cameron alleges that disciplinary proceedings have been initiated against him in a bad faith effort to interfere with his medical practice, which consists substantially of the treatment and care of individuals with Lyme disease.
The plaintiff moves pursuant to Rule 65 of the Federal Rules of Civil Procedure for a preliminary injunction (1) enjoining the hearing on a Statement of Charges brought against the plaintiff by the New York State Board for Professional Medical Conduct, which is scheduled to begin on June 12, 2017, and any subsequent hearings; and (2) enjoining the defendants from taking any further disciplinary action against the plaintiff's medical license, on the theory that the hearing and any such actions constitute a bad faith prosecution in violation of the plaintiff's constitutional rights and the Sherman Act.
The Court held an evidentiary hearing on the motion for a preliminary injunction on June 6, 2017. Having assessed the credibility of the witnesses and reviewed the evidence, the Court makes the following Findings of Fact and reaches the following Conclusions of Law.
The following facts are based on the parties' submissions in connection with the preliminary injunction, and the evidence elicited at the hearing before the Court.
The plaintiff is a medical doctor based in Mount Kisco, New York whose practice consists primarily of the diagnosis and treatment of patients affected by chronic Lyme disease. Cameron Aff. in Supp. of Mot. ("Cameron Aff.") ¶ 2. There are at least two different methodologies for the diagnosis and treatment of Lyme disease: one set of guidelines prescribed by the Infectious Disease Society of America ("IDSA") and another prescribed by the International Lyme and Associated Diseases Society ("ILADS").
The Office of Professional Medical Conduct ("OPMC"), an administrative unit within the New York State Department of Health, is charged with investigating misconduct by medical professionals, including physicians, physician assistants, and special assistants. Nemerson Aff. in Opp. to Mot. ("Nemerson Aff.") ¶ 4. The Director must "investigate each complaint received regardless of the source." N.Y. Pub. H. L. § 230(10)(a). The Director of the OPMC may, in its discretion, then present its investigation to a three-person Investigation Committee of the State Board for Professional Medical Conduct ("BPMC"). Nemerson Aff. ¶¶ 10-11; N.Y. Pub. H. L. § 230(10)(a)(iv). The BPMC was created pursuant to New York Public Health Law § 230(1) and is comprised of physicians and laypersons appointed by the Commissioner of Health. Nemerson Aff. ¶ 8; N.Y. Pub. H. L. § 230(1). The BPMC typically acts not as a whole but through three-person Committees comprised of two physicians and one layperson. Nemerson Aff. ¶ 8; N.Y. Pub. H. L. § 230(6). Those committees are authorized to take only certain kinds of actions, all of which are set out in New York Public Health Law § 230. If an investigation is presented to a BPMC Investigation Committee, the individual being investigated has the right to be interviewed by the OMPC in order to provide an explanation of the issues being investigated. N.Y. Pub. H.L. § 230(10)(a)(iii). If a majority of a three-person Investigation Committee of the BPMC concurs with the determination of the Director of the OPMC that a hearing is warranted, the investigation is referred to the Bureau of Professional Misconduct ("Bureau"), where a Statement of Charges against the medical professional is drafted. Nemerson Aff. ¶ 4; N.Y. Pub. H. L. § 230(10)(a)(iv).
Counsel for the Bureau then presents the case to a BPMC Hearing Committee. Nemerson Aff. ¶ 8; N.Y. Pub. H. L. 230(10)(a)(iv), 10(e). A Hearing Committee performs adjudicative functions in cases brought against individuals by the Bureau, including making findings of fact, conclusions concerning whether the charges against the individual should be sustained or dismissed, and, if charges are sustained, determining the appropriate penalty. Nemerson Aff. ¶ 8; N.Y. Pub. H. L. § 230(10)(g). The Hearing Committee is not bound by the rules of evidence, but must base its conclusions on a preponderance of the evidence. N.Y. Pub. H. L. § 230(10)(f). Either party may appeal the determination of the Hearing Committee to the Administrative Review Board for Professional Medical Conduct ("ARB"), which consists of five members of the BPMC, including three physicians and two laypersons. N.Y. Pub. H. L. § 230-c(1), (2). Parties may seek judicial review of the determination of the ARB in an Article 78 proceeding, N.Y. C.P.L.R. § 7801 et seq., or may bypass the ARB altogether by appealing the determination of the Hearing Committee directly in an Article 78 proceeding. N.Y. Pub. H. L. § 230-c(5). The result of the Article 78 proceeding may then be appealed to the Appellate Division, Third Department.
Thus, in sum, an investigation into a physician's medical conduct begins with the Director of the OPMC, who must investigate all complaints of misconduct. Only if the Director finds it appropriate will that investigation be presented to a three-person Investigation Committee of the BPMC. And then, only if — after the physician has the opportunity to be interviewed — the OPMC Director and a majority of the Investigation Committee concur that a Hearing is appropriate will a Statement of Charges be drafted and the case presented to a Hearing Committee for potential discipline.
The OPMC began an initial investigation of Dr. Cameron in 2000 after receiving two complaints about Dr. Cameron's care of certain patients and learning of an investigation of Dr. Cameron by Oxford Health Plans. Nemerson Aff. Ex. B. That initial investigation, which involved Dr. Cameron's care and treatment of eleven patients, lasted throughout 2001 and 2002 before being closed without being presented to a BPMC Investigation Committee.
As part of the investigation Dr. Cameron, accompanied by his lawyer, was interviewed over two days by Dr. Burt Meyers, a medical coordinator, and Patrick Sullivan. Dr. Cameron received a record of that interview, and his lawyer made a follow-up submission including comments and corrections to the interview record.
Upon review of the investigation, Keith Servis, the OPMC Director at the time, determined that a Committee Hearing was warranted and submitted the investigation to a BPMC Investigation Committee in November 2011, which unanimously concurred with the Director's determination. Nemerson Aff. ¶¶ 10, 25. Associate Counsel of the OPMC, in consultation with a medical expert who reviewed the relevant medical records, then drafted a Statement of Charges against Dr. Cameron, which includes allegations of negligent, incompetent, grossly negligent, and grossly incompetent medical practice, and failure to maintain accurate medical records.
A draft Statement of Charges was provided to Dr. Cameron's counsel in or around July 2012, at which point Dr. Cameron filed suit in New York state court.
In February 2017, Dr. Cameron's motion for leave to appeal to the Court of Appeals was denied.
Dr. Cameron filed this action on May 9, 2017, seeking injunctive relief to prevent the conduct of the disciplinary hearing on June 12 or on any date thereafter. ECF No. 2. The defendants include Dr. Howard Zucker, the Commissioner of the New York State Department of Health; Keith Servis, the former Director of the OPMC, and a variety of other individuals currently or formerly associated with the OPMC and BPMC.
The Complaint alleges four causes of action. In the first cause of action, the plaintiff alleges violations of Sections 1 and 2 of the Sherman Antitrust Act, 15 U.S.C. §§ 1 and 2. In essence, the plaintiff claims that the defendants have conspired to place unreasonable restrictions on the medical trade in New York by excluding competitive ILADS guidelines-based medical services. The plaintiff also alleges that the defendants are seeking to form a monopoly of IDSA guidelines-based medical services.
The plaintiff filed a motion for a temporary restraining order and a preliminary injunction, asking this Court to intervene in the state disciplinary proceedings and prevent the Hearing currently scheduled to begin on June 12. The plaintiff argues that such intervention is necessary because the hearing constitutes a bad faith prosecution that has been staged in order to harass the plaintiff and "stamp out ILADS based Lyme disease medical services." Cameron Reply Aff. in Supp. of Mot. ¶ 25; Mem. in Supp. of Mot. p. 7. The plaintiff argues further that he is entitled to a preliminary injunction because the bad faith prosecution itself constitutes irreparable injury, and because the plaintiff is likely to succeed on the merits of his claim for injunctive and declaratory relief. This Court denied the plaintiff's request for a temporary restraining order and scheduled a hearing on the motion for a preliminary injunction. ECF No. 35.
The plaintiff moves for a preliminary injunction: (1) preventing the hearing currently scheduled to begin June 12, 2017, and any hearings thereafter, from occurring; (2) enjoining the defendants from taking "any action" against the plaintiff's medical license; and (3) preventing the defendants from using the medical disciplinary process to restrict the plaintiff's practice of medicine. Proposed Order p. 2. The standards that govern the issuance of a preliminary injunction are well established. "A party seeking a preliminary injunction ordinarily must show: (1) a likelihood of irreparable harm in the absence of the injunction; and (2) either a likelihood of success on the merits or sufficiently serious questions going to the merits to make them a fair ground for litigation, with a balance of hardships tipping decidedly in the movant's favor."
It is plain that the only basis on which the plaintiff seeks a preliminary injunction is the alleged violation of his constitutional right not to be subjected to a disciplinary proceeding brought in bad faith in violation of 42 U.S.C. § 1983. Although the plaintiff asserted antitrust claims in his Complaint, the defendants responded to the motion for a preliminary injunction, in part, by explaining that the plaintiff had not established a likelihood of success on the merits of his antitrust claims. The plaintiff did not respond to those arguments and conceded at the hearing that the antitrust claims cannot entitle the plaintiff to preliminary injunctive relief. In any event, the plaintiff has not attempted to explain how any irreparable antitrust injury would result if the disciplinary hearing moves forward, because the plaintiff remains free to practice medicine during the course of the proceedings in front of the Hearing Committee. There is no restraint on trade and no monopolization.
The threshold issue is whether this Court must abstain from enjoining the state proceedings under
In
In this case, it is plain that the medical disciplinary proceeding, like the attorney disciplinary proceeding in
Rather, Dr. Cameron relies exclusively on the "bad faith" exception to the
The plaintiff has not met this burden. He alleges that the disciplinary proceedings against him were initiated "simply because [he] offer[s] medical services based upon" the ILADS guidelines and that the proceedings are motivated by the defendants' desire to "stamp out ILADS based Lyme disease medical services." Cameron Aff. ¶ 7; Cameron Reply Aff. ¶ 25. Those allegations are conclusory and are not supported by the evidence. At the outset, the plaintiff spends considerable effort arguing that a bad faith prosecution is a violation of his constitutional due process rights.
N.Y. Pub. H. L. § 230(9-b)(emphasis added). The provision also states that "[t]he licensee shall otherwise abide by all other applicable professional requirements."
Rather, the Statement of Charges accuses Dr. Cameron of deviating from minimally accepted standards of care that apply to all doctors and that apply regardless of whether the patient at issue is being treated for Lyme disease in accordance with ILADS guidelines or not. For example, Dr. Cameron is alleged to have continued to provide narcotics to a patient who had a diagnosis of bipolar disorder/personality disorder and narcotics abuse from July 2003 through 2005 even though the patient had moved to Florida. Compl. Ex. A p. 2. In another case, the Statement of Charges allege that, over the course of ten years, the plaintiff treated a patient with an "ongoing and escalating antibiotic regimen" although the patient received only one physical examination during those ten years.
This is only a sampling of the charges. But it is clear that the charges are based on allegations of professional misconduct and not the use of the ILADS modality. Indeed, although the plaintiff alleges that the charges are actually an effort to discipline him for practicing pursuant to the ILADS guidelines, the plaintiff conceded at the hearing that the ILADS guidelines do not allow or advise the conduct alleged in the Statement of Charges.
In response, the plaintiff alleges that the wording of the Statement of Charges is intended to obfuscate the true nature of the proceedings, and "deliberately omits any reference to the actual subject matter which was authorized for prosecution," which the plaintiff argues was "the elimination of Lyme disease medical services provided by ILADS standards." Mem. in Supp. of Mot. p. 15. The plaintiff argues further that the letters sent to him by the OPMC in the course of the investigation confirm that the true nature of the allegations is "restricted to Plaintiff's offering and applying Lyme disease medical services to [patients] by ILADS standards and not by IDSA guidelines."
The letters themselves belie the plaintiff's argument and do not support a finding of bad faith. They simply outline the patients involved in the investigation and offer a brief summary of the "issues under investigation," which include general descriptions such as "[t]he care you rendered to [Patient A]. Specifically, the appropriateness of the care and treatment you rendered to [Patient A] in July 2008 for Lyme disease and complaints of neck pain." Cameron Aff. Ex 2;
In his Complaint the plaintiff pointed to the publication of an article in January 2017 by three authors who are members of the IDSA that was critical of some practices endorsed by the ILADS guidelines. Compl. ¶¶ 62-63. The Complaint also pointed out that Dr. Meyers is a member of the IDSA and attempted to link that fact and the publication of the article to the Statement of Charges dated April 27, 2017.
There is nothing in the Statement of Charges, or anywhere else in the record, to suggest that the charges were initiated for any reason other than that the Investigation Committee and the Director of OPMC agreed that their investigation had revealed deviations from the minimally accepted standards of medical care. The plaintiff's conclusory allegations that the proceedings were initiated solely for the purpose of "stamp[ing] out" ILADS-based treatment is also inconsistent with the plaintiff's failure to identify a single doctor, other than himself, who follows the ILADS guidelines and who has been subjected to disciplinary proceedings. Indeed, the Bureau maintains that — although on average hundreds of disciplinary actions have been initiated each year — only three such actions initiated since the year 2000 have involved the treatment of a patient diagnosed with Lyme disease. Nemerson Aff. ¶ 16. In light of those statistics and the lack of evidence that the disciplinary proceedings were initiated solely for the purpose of eliminating the practice of ILADS-based treatment of Lyme disease, the plaintiff's allegation that the proceedings were brought in bad faith is not credible.
Moreover, Dr. Cameron has not even attempted to establish that the defendants have "no reasonable expectation of obtaining a favorable outcome" at the Hearing as required to establish bad faith.
In addition to the requirement that this Court abstain pursuant to
"A showing of irreparable harm is the single most important prerequisite for the issuance of a preliminary injunction."
For the reasons explained above, the plaintiff has also failed to carry his burden to show that he is likely to succeed on his claim that the proceeding against him was brought in bad faith in violation of his constitutional rights. And the plaintiff has made no effort to show that he is likely to succeed on his antitrust claims.
Finally, the public interest weighs strongly against issuing a preliminary injunction in this case. The state's Board of Professional Medical Conduct — which has a clear interest in protecting the health of the citizens of New York by regulating the practice of medicine — has issued charges against Dr. Cameron.
The foregoing constitutes the Court's Finding of Fact and Conclusions of Law. The Court has considered all of the arguments of the parties. To the extent not specifically addressed, the arguments are either moot or without merit.
For the reasons explained above, the plaintiff's motion for a preliminary injunction is